- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03486340
Prevention of Chest Pain in Chemo-treated Cancer Patients (CATCH)
September 1, 2023 updated by: Vejle Hospital
Prevention of CArdioToxic-related CHest Pain in Cancer Patients Treated With 5-fluorouracil
This is a prospective, exploratory, randomised clinical trial.
Patients with diagnosed cancer that are to be treated with 5-fluorouracil (5-FU) will be randomised into standard oncological treatment or a cardiological assessment prior to the 5-FU treatment.
The investigators hypothesize that aggressive management of ischemic risk factors in asymptomatic patients will reduce the number of hospitalisations and investigations for acute coronary syndrome during and after 5-FU treatment and that patients with high coronary artery calcium scores are more likely to experience chest pain during the treatment with 5-FU.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
200
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Mads D Lyhne, MD
- Phone Number: +45 20450486
- Email: Mads.Dam.Lyhne@rsyd.dk
Study Contact Backup
- Name: Vibeke B Hansen, MD, PhD
- Email: vibeke.brogaard.hansen@rsyd.dk
Study Locations
-
-
-
Vejle, Denmark
- Recruiting
- Departments of Oncology and Medicine, Vejle Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Histologically verified cancer
- First-time treatment with 5-FU/Capecitabine
- Expected remaining lifetime > 6 months
- Informed consent
Exclusion Criteria:
- Known ischemic heart disease
- Ischemia-suspicious symptoms prior to 5-FU treatment
- Ischemia-suspicious ECG-changes prior to 5-FU treatment
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Cardiological assessment
a sub-acute cardiologic assessment and aggressive management of risk factors before oncologic treatment
|
Aggressive ischemic risk factor management
|
No Intervention: Standard treatment
Standard chemotherapeutic treatment
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Acute coronary syndrome
Time Frame: 6 months
|
Composite endpoint of the incidence of overall mortality, chest pain requiring hospital admittance, the incidence of coronary angiography intervention and acute coronary syndrome
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Chest pain
Time Frame: 6 months
|
Incidence of chest pain
|
6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Vibeke B Hansen, MD, PhD, Vejle Hospital
- Study Chair: Lars H Jensen, MD, PhD, Department of Oncology, Vejle Hospital, Denmark
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 11, 2018
Primary Completion (Estimated)
December 30, 2024
Study Completion (Estimated)
June 30, 2025
Study Registration Dates
First Submitted
March 26, 2018
First Submitted That Met QC Criteria
March 26, 2018
First Posted (Actual)
April 3, 2018
Study Record Updates
Last Update Posted (Actual)
September 5, 2023
Last Update Submitted That Met QC Criteria
September 1, 2023
Last Verified
September 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CATCH2018
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chest Pain
-
Clinical Locomotion ScienceOdense University Hospital; University of Southern Denmark; The County of Funen... and other collaboratorsCompletedUndiagnosed Chest Pain | Musculoskeletal Chest Pain | Non-cardiac Chest PainDenmark
-
Academisch Medisch Centrum - Universiteit van Amsterdam...TerminatedFunctional Chest PainNetherlands
-
Atatürk UniversityCompletedPain, Acute | Pain, ChestTurkey
-
Queen's UniversityCompletedChest Pain Atypical SyndromeCanada
-
Universiti Sains MalaysiaCompletedNon Cardiac Chest PainMalaysia
-
Milton S. Hershey Medical CenterCompletedNoncardiac Chest Pain (NCCP)United States
-
Cairo UniversityActive, not recruitingNonspecific Cardiac Chest PainEgypt
-
Fayoum University HospitalCompleted
-
University of Texas Southwestern Medical CenterCompletedAcute Chest PainUnited States
-
Massachusetts General HospitalBracco Diagnostics, IncCompletedChest Pain SyndromeUnited States
Clinical Trials on Cardiologic assessment
-
Instituto de Investigación Hospital Universitario...Hospital Universitario La Paz; Proyecto Ictus- Grupo Estudio Enfermedades CerebroVasculares...RecruitingAtrial Fibrillation | Stroke, Ischemic | Cryptogenic Stroke | Atrial DilatationSpain
-
NYU Langone HealthSuspended
-
Columbia UniversityNational Heart, Lung, and Blood Institute (NHLBI)CompletedDepression | Heart DiseasesUnited States
-
Istanbul University - Cerrahpasa (IUC)Active, not recruitingHealthy | Physical InactivityTurkey
-
Gazi UniversityUnknownPhysical Functional Performance | Postural Balance | Complete Tear, Ankle, Lateral LigamentTurkey
-
Assistance Publique - Hôpitaux de ParisCompletedShock | Cerebral Lesion | Arterial HypotensionFrance
-
McGill UniversityCompletedCommunication | Gait | Emotions | MusicCanada
-
Vanderbilt University Medical CenterNational Institute of Mental Health (NIMH)RecruitingAutism Spectrum DisorderUnited States
-
Université Catholique de LouvainRecruiting
-
Hacettepe UniversityCompletedMuscular Endurance And Its Association With Neck Pain, Disability, Neck Awareness, And KinesiophobiaCervical Disc HerniationTurkey